ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01409135
Recruitment Status : Completed
First Posted : August 4, 2011
Last Update Posted : October 7, 2015
Sponsor:
Collaborators:
Agensys, Inc.
Seattle Genetics, Inc.
Information provided by (Responsible Party):
Astellas Pharma Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2015
  Actual Study Completion Date : April 2015